Structural and signaling mechanisms of TAAR1 enabled preferential agonist design
Cell · 2023-11 · 186 (24) · 5347-5362.e24
DOI: 10.1016/j.cell.2023.10.014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell, 2023-11. Verfasst von Pan Shang und 27 weiteren Autor:innen. Beteiligte Einrichtung: NHC Key Laboratory of Otorhinolaryngology, Qilu hospital and School of Basic Medical Sciences, Shandong University, Jinan, Shandong 250012, China; Ad…. Hauptthemen laut MEDLINE: Receptors, G-Protein-Coupled, Signal Transduction. Die Arbeit wurde bisher 58-mal zitiert (Crossref) und nennt 74 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- NHC Key Laboratory of Otorhinolaryngology, Qilu hospital and School of Basic Medical Sciences, Shandong University, Jinan, Shandong 250012, China; Advanced Medical Research Institute and Meili Lake Translational Researc…
- NHC Key Laboratory of Otorhinolaryngology, Qilu hospital and School of Basic Medical Sciences, Shandong University, Jinan, Shandong 250012, China.
- Department of General Surgery, Qilu Hospital of Shandong University, Jinan, Shandong 250012, China.
- Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Shandong University, 44 West Culture Road, Jinan, Shandong 250012, China.
- Advanced Medical Research Institute and Meili Lake Translational Research Park, Shandong University, Jinan, Shandong 250012, China; Biomedical Research Center for Structural Analysis, Shandong University, No.44 Wenhua X…
- Advanced Medical Research Institute and Meili Lake Translational Research Park, Shandong University, Jinan, Shandong 250012, China.
Zitieren
APA
Shang, P., Rong, N., Jiang, J. J., Cheng, J., Zhang, M. H., Kang, D., Qi, L., Guo, L., Yang, G. M., Liu, Q., Zhou, Z., Li, X. B., Zhu, K. K., Meng, Q. B., Han, X., Yan, W., Kong, Y., Yang, L., Wang, X., …, & Sun, J. P. (2023). Structural and signaling mechanisms of TAAR1 enabled preferential agonist design. Cell, 186(24), 5347-5362.e24. https://doi.org/10.1016/j.cell.2023.10.014
Vancouver
Shang P, Rong N, Jiang JJ, Cheng J, Zhang MH, Kang D, et al. Structural and signaling mechanisms of TAAR1 enabled preferential agonist design. Cell. 2023;186(24):5347-5362.e24. doi:10.1016/j.cell.2023.10.014
BibTeX
@article{Shang2023,
author = {Shang, Pan and Rong, Naikang and Jiang, Jing-Jing and Cheng, Jie and Zhang, Ming-Hui and Kang, Dongwei and Qi, Lei and Guo, Lulu and Yang, Gong-Ming and Liu, Qun and Zhou, Zhenzhen and Li, Xiao-Bing and Zhu, Kong-Kai and Meng, Qing-Biao and Han, Xiang and Yan, Wenqi and Kong, Yalei and Yang, Lejin and Wang, Xiaohui and Lei, Dapeng and Feng, Xin and Liu, Xinyong and Yu, Xiao and Wang, Yue and Li, Qian and Shao, Zhen-Hua and Yang, Fan and Sun, Jin-Peng},
title = {Structural and signaling mechanisms of TAAR1 enabled preferential agonist design},
journal = {Cell},
year = {2023},
volume = {186},
number = {24},
pages = {5347--5362.e24},
doi = {10.1016/j.cell.2023.10.014}
}
EUVIMED